Trial Profile
Effects of flibanserin on pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy premenopausal women: A two-way crossover randomised study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2017
Price :
$35
*
At a glance
- Drugs Flibanserin (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Female sexual dysfunction
- Focus Pharmacokinetics
- 07 Dec 2017 New trial record
- 30 Nov 2017 Results published in the Clinical Therapeutics